| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/11/2004 | US20040048863 Treating osteoarthritis or rheumatoid arthritis |
| 03/11/2004 | US20040048862 Chemical compounds |
| 03/11/2004 | US20040048859 Substituted glutarimides and their use as inhibitors of IL-12 production |
| 03/11/2004 | US20040048858 Chalcone derivatives and their use to treat diseases |
| 03/11/2004 | US20040048857 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 03/11/2004 | US20040048855 Inhibitors of interleukin 1-beta converting enzyme |
| 03/11/2004 | US20040048853 Compounds, compositions, and methods |
| 03/11/2004 | US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/11/2004 | US20040048828 Immunosuppressive agent and food |
| 03/11/2004 | US20040048820 Prevention or therapy of cardiovascular complications |
| 03/11/2004 | US20040048815 Low-molecular serine proteases inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals |
| 03/11/2004 | US20040048803 Treatment of thrombosis by administering a CD154 inhibitor, especially a metalloproteinase inhibitor. |
| 03/11/2004 | US20040048799 Combination therapy using a TNF binding protein for treating TNF-mediated diseases |
| 03/11/2004 | US20040048795 Stimulating a vagus nerve pathway in the brain; inhibiting apoptosis of a cardiac myocyte |
| 03/11/2004 | US20040048789 Pharmaceutical compositions |
| 03/11/2004 | US20040048774 Inhibitors of IMPDH enzyme |
| 03/11/2004 | US20040048772 Preventives for arthritis |
| 03/11/2004 | US20040048372 Extracting and recovering embryonic-like stem cells, including pluripotent or multipotent stem cells, from an exsanguinated human placenta; use of the isolated and perfused placenta as a bioreactor in which to propagate endogenous/exogenous cells |
| 03/11/2004 | US20040048338 IL-17 receptor like molecules and uses thereof |
| 03/11/2004 | US20040048325 Glycosyltransferase inhibitors |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048266 Regulation of human membrane-type serine protease |
| 03/11/2004 | US20040048263 Novel g protein-coupled receptor protein and dna thereof |
| 03/11/2004 | US20040047896 Composition for improving age-related physiological deficits and increasing longevity |
| 03/11/2004 | US20040047863 Administering TNF(Tumor necrosis factor) binding protein and at least one additional anti-inflammatory drug, for therapy of an acute or chronic inflammatory disease |
| 03/11/2004 | US20040047860 Antibodies to human mcp-1 |
| 03/11/2004 | US20040047856 Colorstrum-based composition |
| 03/11/2004 | US20040047851 Treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingomyelinase inhibitors effective to decrease |
| 03/11/2004 | US20040047832 Cosmetic and/or dermopharmaceutical preparations containing leaf extracts of the plant argania spinosa |
| 03/11/2004 | US20040047807 Neurotoxic substances, which have a toxic effect in particular for the axon and the nociceptive nerve endings, for the preparation of an agent for the treatment of joint pain. |
| 03/11/2004 | DE10240418A1 Formulierung zur Einschleusung von Nukleinsäuren in eukaryotische Zellen Formulation for the introduction of nucleic acids in eukaryotic cells |
| 03/11/2004 | DE10240343A1 Peroxynitrit-Umlagerungskatalysatoren Peroxynitrite rearrangement catalysts |
| 03/11/2004 | CA2706622A1 Lps activation of phagocytic activity |
| 03/11/2004 | CA2537158A1 Cxcr4 antagonist and use thereof |
| 03/11/2004 | CA2497047A1 Adzymes and uses thereof |
| 03/11/2004 | CA2496920A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | CA2496812A1 Novel processes and intermediates for preparing triazolo-pyridines |
| 03/11/2004 | CA2496580A1 3-(sulfonamidoethyl)-indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases |
| 03/11/2004 | CA2496523A1 Human antihuman interleukin-6 antibody and fragment of the antibody |
| 03/11/2004 | CA2495914A1 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | CA2495853A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12 |
| 03/11/2004 | CA2495437A1 Novel crystal |
| 03/11/2004 | CA2493199A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions |
| 03/11/2004 | CA2488739A1 Nitrogen-containing aromatic derivatives |
| 03/10/2004 | EP1396542A2 Novel P-selectin ligand protein |
| 03/10/2004 | EP1396492A1 Prodrug of an ice inhibitor |
| 03/10/2004 | EP1396491A2 2-substituted 4,5-diaryl-imidazoles and their use as p38 MAP kinase inhibitors |
| 03/10/2004 | EP1396488A1 Fused heterocyclic compound and medicinal use thereof |
| 03/10/2004 | EP1396487A1 Phenylpyridine carbonyl piperazine derivative |
| 03/10/2004 | EP1396266A1 Aqueous cilostazol preparation for injection |
| 03/10/2004 | EP1395834A2 Screening method which uses bnpi and dnpi |
| 03/10/2004 | EP1395684A2 New polynucleotides and polypeptides of the ifnalpha-7 gene |
| 03/10/2004 | EP1395611A2 Methods and compositions for treating respiratory mucin production associated disease conditions |
| 03/10/2004 | EP1395605A2 Polymeric immunoglobulin fusion proteins that target low-affinity fcgamma receptors |
| 03/10/2004 | EP1395604A1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives |
| 03/10/2004 | EP1395582A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 03/10/2004 | EP1395581A2 Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins |
| 03/10/2004 | EP1395572A1 Process for preparing a thiazole ppar-ligand and polymorphs thereof |
| 03/10/2004 | EP1395568A1 4-aminopyrimidine derivatives |
| 03/10/2004 | EP1395567A1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395566A1 Tricyclic compounds useful as angiotensin ii agonists |
| 03/10/2004 | EP1395562A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- 2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 03/10/2004 | EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production |
| 03/10/2004 | EP1395558A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395554A1 Substituted carbazoles as inhibitors of spla2 |
| 03/10/2004 | EP1395553A1 Pyrrolidine derivatives as factor xa inhibitors |
| 03/10/2004 | EP1395538A1 Vitamin d analogues |
| 03/10/2004 | EP1395305A1 Using supercritical fluids to infuse therapeutic on a medical device |
| 03/10/2004 | EP1395285A2 Reagents and methods for modulating dkk-mediated interactions |
| 03/10/2004 | EP1395279A2 Use of neublastin polypeptides for treating neuropathic pain |
| 03/10/2004 | EP1395277A1 The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis |
| 03/10/2004 | EP1395269A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 03/10/2004 | EP1395268A1 A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation |
| 03/10/2004 | EP1395259A2 Urazole compounds useful as anti-inflammatory agents |
| 03/10/2004 | EP1395242A1 Liquid pharmaceutical composition |
| 03/10/2004 | EP1395238A1 Skin preparation |
| 03/10/2004 | EP1177196B1 Heteroaryl diazabicycloalkanes, their preparation and use |
| 03/10/2004 | EP1157025B1 Pyrazolopyridines |
| 03/10/2004 | EP1066044B1 Dextran formulations for treatment of inflammatory joint disorders |
| 03/10/2004 | EP1030660B1 A transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt, and the manufacturing method thereof |
| 03/10/2004 | EP0983256B1 Triptolide derivatives useful in the treatment of autoimmune diseases |
| 03/10/2004 | EP0873050B1 Pharmaceutical compositions for prevention and treatment of ulcerative colitis |
| 03/10/2004 | CN1481390A Immunomodulatory peptidesderived from heat shock proteins and uses thereof |
| 03/10/2004 | CN1481377A Cyclic Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF alhpa |
| 03/10/2004 | CN1481376A Oxybenzamides derivatives as factor xa inhibitors |
| 03/10/2004 | CN1481373A 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 03/10/2004 | CN1481372A 1,1-dioxo-2H-1,2-benzothiazine-3-carboxamide derivatives, method for preparing same and pharmaceutical compsns comprising same |
| 03/10/2004 | CN1481370A Quinazoline derivatives, medicaments contg. said compounds, their utilization and method for prodn. thereof |
| 03/10/2004 | CN1481367A Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 03/10/2004 | CN1481364A Urea and urethane derivatives as integrin inhibitors |
| 03/10/2004 | CN1481358A Carboxylic acid amide derivatives and their use in treatment of thromboembolic diseases and tumours |
| 03/10/2004 | CN1481253A Drugs and foods improving quality of life and process for producng same |
| 03/10/2004 | CN1481242A Pharmaceutical formulation contg thienopyrimidines and antithrombotics, calcium-antagonists, prostaglandins or prostaglandin derivatives |
| 03/10/2004 | CN1481238A Aniline derivatives or salts thereof and cytokine prodn inhibitors contg. same |
| 03/10/2004 | CN1481236A Aerogel powder comprising therapeutic agents |
| 03/10/2004 | CN1480522A Medicinal wine compsn and its prepn. method |
| 03/10/2004 | CN1480461A Metching substance with flavone contained in erigeron breviscapus as ligand and its usage |
| 03/10/2004 | CN1480217A Medicinal preparation and its prepn. and application |
| 03/10/2004 | CN1480209A Method for producing compound preparation of propolis |
| 03/10/2004 | CN1480207A Spore of gandoderma lucidum for treating disease of autoimmunity |